| Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study ME Wacker, RA Jörres, H Schulz, J Heinrich, S Karrasch, A Karch, A Koch, ... Respiratory medicine 111, 39-46, 2016 | 130 | 2016 |
| Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities ME Wacker, RA Jörres, A Karch, S Wilke, J Heinrich, S Karrasch, A Koch, ... BMC Pulmonary Medicine 16 (1), 1, 2016 | 123 | 2016 |
| Peripheral Artery Disease and its Clinical Relevance in Patients with COPD in the COSYCONET Study S Houben-Wilke, RA Jörres, R Bals, FME Franssen, S Gläser, R Holle, ... American journal of respiratory and critical care medicine 195 (2), 189-197, 2016 | 118* | 2016 |
| Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic S Houben-wilke, AJ Rudolf, ME Wacker, T Welte, EFM Wouters, ... | 115 | 2017 |
| Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies S Ulrich, R Holle, M Wacker, R Stark, A Icks, B Thorand, A Peters, M Laxy BMJ Open 6 (11), e012527, 2016 | 92 | 2016 |
| The association of smoking status with healthcare utilisation, productivity loss and resulting costs: results from the population-based KORA F4 study M Wacker, R Holle, J Heinrich, KH Ladwig, A Peters, R Leidl, P Menn BMC health services research 13 (1), 278, 2013 | 91 | 2013 |
| Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry—The EXCITING-ILD Registry M Kreuter, FJF Herth, M Wacker, R Leidl, A Hellmann, M Pfeifer, J Behr, ... BioMed Research International 2015, 2015 | 71 | 2015 |
| Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review MB Huber, ME Wacker, CF Vogelmeier, R Leidl PloS one 10 (7), e0132670, 2015 | 70 | 2015 |
| The revised GOLD 2017 COPD categorization in relation to comorbidities K Kahnert, P Alter, D Young, T Lucke, J Heinrich, RM Huber, J Behr, ... Respiratory Medicine 134, 79-85, 2018 | 62 | 2018 |
| Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort K Kahnert, T Lucke, RM Huber, J Behr, F Biertz, A Vogt, H Watz, P Alter, ... PLoS One 12 (5), e0177501, 2017 | 55 | 2017 |
| Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies–A Novel Stepwise Approach by Evaluation of Medication T Lucke, R Herrera, M Wacker, R Holle, F Biertz, D Nowak, RM Huber, ... PLOS ONE 11 (10), e0163408, 2016 | 52 | 2016 |
| Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review MB Huber, ME Wacker, CF Vogelmeier, R Leidl | 52 | 2015 |
| Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios M Hoogendoorn, TL Feenstra, Y Asukai, S Borg, RN Hansen, SA Jansson, ... Value in Health 17 (5), 525-536, 2014 | 50 | 2014 |
| Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothetical Treatment Scenarios M Hoogendoorn, T Feenstra, Y Asukai, S Borg, RN Hansen, SA Jansson, ... Value in Health 7 (17), A557-A558, 2014 | 50* | 2014 |
| Cost-components of lung cancer care within the first three years after initial diagnosis in context of different treatment regimens L Schwarzkopf, M Wacker, R Holle, R Leidl, C Günster, JB Adler, ... Lung Cancer 90 (2), 274-280, 2015 | 48 | 2015 |
| Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and … ME Wacker, RA Jörres, A Karch, A Koch, J Heinrich, S Karrasch, H Schulz, ... Respiratory Research 17 (1), 81, 2016 | 43 | 2016 |
| Health-related quality of life and chronic obstructive pulmonary disease in early stages-longitudinal results from the population-based KORA cohort in a working age population ME Wacker, M Hunger, S Karrasch, J Heinrich, A Peters, H Schulz, ... BMC pulmonary medicine 14 (1), 134, 2014 | 34 | 2014 |
| Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET D Byng, JI Lutter, ME Wacker, RA Jörres, X Liu, S Karrasch, H Schulz, ... International Journal of Chronic Obstructive Pulmonary Disease 14, 1423-1439, 2019 | 30 | 2019 |
| The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort ME Wacker, K Kitzing, RA Jörres, R Leidl, H Schulz, S Karrasch, A Karch, ... International Journal of Chronic Obstructive Pulmonary Disease 12, 3437, 2017 | 28 | 2017 |
| External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting M Hoogendoorn, TL Feenstra, Y Asukai, AH Briggs, RN Hansen, R Leidl, ... Value in Health 20 (3), 397-403, 2017 | 27 | 2017 |
